Trump's continued pursuit of policy priorities, including recent executive actions on healthcare costs and drug pricing, combined with the absence of any official statements, health disclosures, or institutional pressures indicating an early departure, underpins the overwhelming trader consensus against resignation by the end of 2026. Speculation from political opponents, such as predictions tied to post-midterm dynamics or external conflicts, has not translated into verifiable developments or shifts in the president's public posture. This pricing aligns with historical patterns for U.S. presidents serving second terms without constitutional term limits barring completion. Realistic factors that could still alter the outcome include significant personal health events, major scandals prompting congressional action, or an unanticipated personal decision following 2026 midterm results.